Skip to navigation Skip to content

Gastric cancer (GC) Programs in Pharmaceutical Benefits Scheme (PBS) 012-18051116



This document outlines details of PBS-subsidised trastuzumab for patients with gastric cancer (GC).

GC and listing dates

Advanced GC refers to metastatic (Stage IV) HER2 positive adenocarcinoma of the stomach or gastro-oesophageal junction.

Listing dates:

  • trastuzumab - 1 January 2016

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex Drugs Programs team and choose the option relevant to the condition treated.

The Resources page contains links to contact details, item and restriction codes, the PBS schedule and the Services Australia website.

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)